Literature DB >> 17219167

Small trials focusing on surrogate end points may be uninformative.

Harri Hemilä.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17219167     DOI: 10.1007/s00421-006-0387-2

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


× No keyword cloud information.
  7 in total

1.  [Critical evaluation of vitamin C as a prophylactic and therapeutic agent in colds].

Authors:  G RITZEL
Journal:  Helv Med Acta       Date:  1961-01

2.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

Review 3.  Surrogate end points in clinical trials: are we being misled?

Authors:  T R Fleming; D L DeMets
Journal:  Ann Intern Med       Date:  1996-10-01       Impact factor: 25.391

4.  The effect of 2 weeks vitamin C supplementation on immunoendocrine responses to 2.5 h cycling exercise in man.

Authors:  Glen Davison; Michael Gleeson
Journal:  Eur J Appl Physiol       Date:  2006-05-10       Impact factor: 3.078

Review 5.  Vitamin C supplementation and respiratory infections: a systematic review.

Authors:  Harri Hemilä
Journal:  Mil Med       Date:  2004-11       Impact factor: 1.437

6.  Vitamin C prophylaxis in marine recruits.

Authors:  H A Pitt; A M Costrini
Journal:  JAMA       Date:  1979-03-02       Impact factor: 56.272

7.  Vitamin C for preventing and treating the common cold.

Authors:  Robert M Douglas; Harri Hemilä
Journal:  PLoS Med       Date:  2005-06-28       Impact factor: 11.069

  7 in total
  1 in total

Review 1.  Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.

Authors:  Qian Shi; Daniel J Sargent
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.